Thiazolidinediones: the Forgotten Diabetes Medications

Role of Insulin Resistance in Human Disease

Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962

Macrophages, inflammation, and insulin resistance

Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733

Fat and Beyond: The Diverse Biology of PPARγ

Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940

Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome

Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,718

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

(2006) · The Lancet · doi:10.1016/s0140-6736(06)69420-8 · Cited by 1,706

Islet cell failure in type 2 diabetes

Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690

Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study

Hossain, A., Rahman, M. E., Faruqe, M. O., Saif, A., Suhi, S., Zaman, R., Hirad, A. H., Matin, M. N., Rabbee, M. F., & Baek, K.-H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040483 · Cited by 24

Advances in the Insulin–Heart Axis: Current Therapies and Future Directions

Caturano, A., Vetrano, E., Galiero, R., Sardu, C., Rinaldi, L., Russo, V., Monda, M., Marfella, R., & Sasso, F. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810173 · Cited by 24

PPARγ-dependent remodeling of translational machinery in adipose progenitors is impaired in obesity

Siqueira, M. K. D., Li, G., Zhao, Y., Wang, S., Ahn, I. S., Tamboline, M., Hildreth, A. D., Larios, J., Schcolnik‐Cabrera, A., Nouhi, Z., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114945 · Cited by 22

Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor

Nelson, M. L., Pfeifer, J. A., Hickey, J. P., Collins, A. E., & Kalisch, B. E. (2023) · Biology · doi:10.3390/biology12071042 · Cited by 22

Association of Pioglitazone With Major Adverse Cardiovascular Events, All-Cause Mortality, and Heart Failure Hospitalizations: A Systematic Review

Sheikh, I. M., Hassan, O. A., Adam, S. M., Ali, A. I., Ogedegbe, O. J., Tabowei, G., Barbarawi, A., Yussuf, F. M., & Nor, M. A. (2023) · Cureus · doi:10.7759/cureus.46911 · Cited by 28

Comparative effects of glucose-lowering agents on endothelial function and arterial stiffness in patients with type 2 diabetes: A network meta-analysis

Kim, H., Choi, C. U., Rhew, K., Park, J., Lim, Y., Kim, M. G., & Kim, K. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117490 · Cited by 21

Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide ‐1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta‐analysis, and real‐world study from an international federated database

Anson, M., Henney, A. E., Zhao, S. S., Hernández, G., Lip, G. Y. H., Cuthbertson, D. J., Nabrdalik, K., & Alam, U. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15576 · Cited by 21

18:0 Lyso PC, a natural product with potential PPAR-γ agonistic activity, plays hypoglycemic effect with lower liver toxicity and cardiotoxicity in db/db mice

Ma, Y., Du, X., Zhao, D., Tang, K., Wang, X., Guo, S., Li, X., Mei, S., Sun, N., Liu, J., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.059 · Cited by 20

A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis

Collongues, N., Becker, G., Jolivel, V., Ayme‐Dietrich, E., Seze, J. D., Binamé, F., Patte‐Mensah, C., Monassier, L., & Mensah‐Nyagan, A. G. (2022) · Neurology and Therapy · doi:10.1007/s40120-022-00363-7 · Cited by 22

Therapeutic application of natural compounds for skeletal muscle-associated metabolic disorders: A review on diabetes perspective

Ahmad, K., Shaikh, S., Lim, J. H., Ahmad, S. S., Chun, H. J., Lee, E. J., & Choi, I. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115642 · Cited by 25

Ultrasound-assisted synthesis of 4-thiazolidinone Schiff bases and their antioxidant, α-glucosidase, α-amylase inhibition, mode of inhibition and computational studies

Seboletswe, P., Kumar, G., Kubone, L., Olofinsan, K. A., Idris, A., Islam, M. S., & Singh, P. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03268-2 · Cited by 19

The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment

Zhan, Z., Liu, L., Cheng, M., Gao, Y., & Zhou, W. (2022) · Journal of Immunology Research · doi:10.1155/2022/2651790 · Cited by 20

The Natural Sweetener Stevia: An Updated Review on its Phytochemistry, Health Benefits, and Anti-diabetic Study

Patel, S., & Navale, A. M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230501210803 · Cited by 19

Novel Approaches for the Management of Type 2 Diabetes Mellitus: An Update

Kumar, A., Mazumder, R., Rani, A., Pandey, P., & Khurana, N. (2023) · Current Diabetes Reviews · doi:10.2174/0115733998261903230921102620 · Cited by 21

Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?

Odimegwu, C. L., Uwaezuoke, S. N., Chikani, U. N., Mbanefo, N. R., Adiele, K., Nwolisa, C. E., Eneh, C. I., Ndiokwelu, C. O., Okpala, S. C., Ogbuka, F. N., et al. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s479077 · Cited by 22

Metabolism-based approaches for autosomal dominant polycystic kidney disease

Bakaj, I., & Pocai, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1126055 · Cited by 18

1,3,4-Oxadiazole Scaffold in Antidiabetic Drug Discovery: An Overview

Gupta, O., Chawla, G., & Pradhan, T. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575298181240410041029 · Cited by 18

Effects of Antidiabetic Drugs on Endothelial Function in Patients With Type 2 Diabetes Mellitus: A Bayesian Network Meta-Analysis

Wang, Y., Yao, M., Wang, J., Liu, H., Zhang, X., Zhao, L., Hu, X., Guan, H., & Lyu, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.818537 · Cited by 18

Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions

Jia, I. L. J., Zampetti, S., Pozzilli, P., & Buzzetti, R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111879 · Cited by 27

Metabolic Profiling of Female Tg2576 Mouse Brains Provides Novel Evidence Supporting Intranasal Low-Dose Pioglitazone for Long-Term Treatment at an Early Stage of Alzheimer’s Disease

Wong, L. R., Wong, P., & Ho, P. C. (2020) · Biomedicines · doi:10.3390/biomedicines8120589 · Cited by 16

Silencing of DsbA-L gene impairs the PPARγ agonist function of improving insulin resistance in a high-glucose cell model

Zhou, X., Li, J., Wei, L., He, M., Jia, J., Zhang, J., Wang, S., & Feng, L. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000432 · Cited by 17

Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway In Vivo and In Vitro

He, Q., Chen, B., Wang, G., Zhou, D., Zeng, H., Li, X., Song, Y., Yu, X., Liang, W., Chen, H., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.842879 · Cited by 19

Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis

Melin, J. M., Forslund, M., Alesi, S. J., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A. S., Witchel, S. F., Mousa, A., et al. (2024) · Clinical Endocrinology · doi:10.1111/cen.14983 · Cited by 16

Managing Post-Transplant Diabetes Mellitus after Kidney Transplantation: Challenges and Advances in Treatment

Rudzki, G., Knop-Chodyła, K., Piasecka, Z., Kochanowska-Mazurek, A., Głaz, A., Wesołek, E., & Woźniak, M. M. (2024) · Pharmaceuticals · doi:10.3390/ph17080987 · Cited by 18

Exploring the recent molecular targets for diabetes and associated complications

Gupta, A. K., Behl, T., Sehgal, A., Bhardwaj, S., Singh, S., Sharma, N., & Hafeez, A. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06294-0 · Cited by 17

Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries

Dutt, C., Salles, J. E. N., Joshi, S., Nair, T., Chowdhury, S., Mithal, A., Mohan, V., Kasliwal, R., Sharma, S., Tijssen, J. G. P., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s333787 · Cited by 16

PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells

Chen, Z., Ghavimi, S. A. A., Wu, M., McNamara, J., Barreiro, O., Maridas, D. E., Kratchmarov, R., Siegel, A., Djeddi, S., Gutiérrez‐Arcelus, M., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.165324 · Cited by 15

Probiotics intervention for type 2 diabetes mellitus therapy: a review from proposed mechanisms to future prospects

Li, X., Xia, Y., Song, X., Xiong, Z., Ai, L., & Wang, G. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2387765 · Cited by 16

Chalcone and derived natural products: versatile scaffolds for multiple targets in treatment of Type 2 diabetes

Marulkar, V. S., & Bhatia, N. M. (2024) · Phytochemistry Reviews · doi:10.1007/s11101-024-10007-3 · Cited by 15

Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential

Xu, R., Zhang, L., Pan, H., & Zhang, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1464655 · Cited by 19

Anti-Diabetic Therapy, Heart Failure and Oxidative Stress: An Update

Koniari, I. C., Velissaris, D., Kounis, N. G., Koufou, E., Artopoulou, E., GREGORIO, C. D., Mplani, V., Paraskevas, T., Tsigkas, G., Hung, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164660 · Cited by 16

The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening

Mueller, S. L., Chrysanthopoulos, P. K., Halili, M. A., Hepburn, C., Nebl, T., Supuran, C. T., Nocentini, A., Peat, T. S., & Poulsen, S. (2021) · Molecules · doi:10.3390/molecules26103010 · Cited by 14

Systems Biology to Address Unmet Medical Needs in Neurological Disorders

Savelieff, M. G., Noureldein, M. H., & Feldman, E. L. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2265-0_13 · Cited by 15

The protective role of peroxisome proliferator-activated receptor gamma in lipotoxic podocytes

García-Carrasco, A., Izquierdo‐Lahuerta, A., Valverde, Á. M., Ni, L., Flores-Salguero, E., Coward, R. J., & Medina‐Gómez, G. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159329 · Cited by 14

GIPR Agonism Enhances TZD-Induced Insulin Sensitivity in Obese IR Mice

Furber, E. C., Hyatt, K., Collins, K. A. L., Yu, X., Droz, B. A., Holland, A. K., Friedrich, J. L., Wojnicki, S., Konkol, D. L., O’Farrell, L. S., et al. (2023) · Diabetes · doi:10.2337/db23-0172 · Cited by 16

Structure-based screening, optimization and biological evaluation of novel chrysin-based derivatives as selective PPARγ modulators for the treatment of T2DM and hepatic steatosis

Ma, L., Tang, J., Chen, F., Liu, Q., Huang, J., Liu, X., Zhou, Z., & Yi, W. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116728 · Cited by 14

Identification of Novel PPARγ Partial Agonists Based on Virtual Screening Strategy: In Silico and In Vitro Experimental Validation

Lian, Y.-E., Wang, M., Ma, L., Yi, W., Liao, S., Gao, H., & Zhou, Z. (2024) · Molecules · doi:10.3390/molecules29204881 · Cited by 14

Senna petersiana (Bolle) leaf extract modulates glycemic homeostasis and improves dysregulated enzyme activities in fructose-fed streptozotocin-induced diabetic rats

Olofinsan, K. A., Salau, V. F., Erukainure, O. L., & Islam, M. S. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115998 · Cited by 14

Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study

Mørk, F. B., Madsen, J. O. B., Jensen, A. K., van Hall, G., Pilgaard, K. A., Pociot, F., & Johannesen, J. (2021) · Diabetic Medicine · doi:10.1111/dme.14702 · Cited by 14

Can Newer Anti-Diabetic Therapies Delay the Development of Diabetic Nephropathy?

Aziz, S., Ghadzi, S. M. S., Sulaiman, S. A. S., Hanafiah, N. H. M., & Harun, S. N. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_497_21 · Cited by 13

The Impact of Punica granatum Linn and Its Derivatives on Oxidative Stress, Inflammation, and Endothelial Function in Diabetes Mellitus: Evidence from Preclinical and Clinical Studies

Mokgalaboni, K., Dlamini, S. T., Phoswa, W. N., Modjadji, P., & Lebelo, S. L. (2023) · Antioxidants · doi:10.3390/antiox12081566 · Cited by 13

MitoNEET Provides Cardioprotection via Reducing Oxidative Damage and Conserving Mitochondrial Function

Tam, E., & Sweeney, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010480 · Cited by 13

Antidiabetic potential of thiazolidinedione derivatives with efficient design, molecular docking, structural activity relationship, and biological activity: an update review (2021–2023)

Sharma, A., Kumar, N., Gulati, H. K., Rana, R., Jyoti, J., Khanna, A., Muskan, Singh, J. V., & Bedi, P. M. S. (2024) · Molecular Diversity · doi:10.1007/s11030-023-10793-6 · Cited by 13

Diabetes in COVID-19 patients: challenges and possible management strategies

Reshad, R. A. I., Riana, S. H., Chowdhury, M. A.-B., Moin, A. T., Miah, F., Sarkar, B., & Jewel, N. A. (2021) · Egyptian Journal of Bronchology · doi:10.1186/s43168-021-00099-2 · Cited by 13

Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern

Setz, C., Große, M., Auth, J., Fröba, M., Rauch, P., Bausch, A., Wright, M. B., & Schubert, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126830 · Cited by 15

Risk of Pancreatitis With Incretin Therapies Versus Thiazolidinediones in the Veterans Health Administration

Wilhite, K., Reid, J. M., & Lane, M. (2024) · Annals of Pharmacotherapy · doi:10.1177/10600280231205490 · Cited by 12

A Propolis‐Derived Small Molecule Tectochrysin Ameliorates Type 2 Diabetes in Mice by Activating Insulin Receptor β

Zhang, J., Wu, J. W., Shi, X., Li, D., Yang, S., Zhang, R., Xia, B., & Yang, G. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300283 · Cited by 13

Impact of natural compounds on peroxisome proliferator-activated receptor: Molecular effects and its importance as a novel therapeutic target for neurological disorders

Zhu, Z., Guan, Y., Gao, S., Guo, F., Liu, D., & Zhang, H. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.117170 · Cited by 12

The dual challenge of diabesity: pathophysiology, management, and future directions

Sindhwani, R., Bora, K. S., & Hazra, S. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03713-4 · Cited by 18

Identification of Novel Organo-Se BTSA-Based Derivatives as Potent, Reversible, and Selective PPARγ Covalent Modulators for Antidiabetic Drug Discovery

Chen, F., Liu, Q., Ma, L., Yan, C., Zhang, H., Zhou, Z., & Yi, W. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02803 · Cited by 12

Brain Expression, Physiological Regulation and Role in Motivation and Associative Learning of Peroxisome Proliferator-activated Receptor γ

Moosecker, S., Pissioti, A., Leidmaa, E., Harb, M. R., Dioli, C., Gassen, N. C., Yu, S., Gazea, M., Catania, C., Anderzhanova, E., et al. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.10.029 · Cited by 12

Meroterpenoids containing benzopyran or benzofuran motif from Ganoderma cochlear

Qin, F., Wang, D.-W., Xu, T., Zhang, B.-S., & Cheng, Y. (2022) · Phytochemistry · doi:10.1016/j.phytochem.2022.113184 · Cited by 12

Unmet Needs in the Treatment of Childhood Type 2 Diabetes: A Narrative Review

Tamborlane, W. V., & Shehadeh, N. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02642-7 · Cited by 12

Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature

Rahimi, L., Malek, M., Ismail‐Beigi, F., & Khamseh, M. E. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01417-8 · Cited by 12

Identification of MDM2, YTHDF2 and DDX21 as potential biomarkers and targets for treatment of type 2 diabetes

Zheng, J., Chen, X., Wu, L., Zhou, Y., Wang, Z., Li, J., Liu, Y., Ge, P., Berggren, P., Zheng, X., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.10.019 · Cited by 12

Treatment options following metformin in primary prevention populations with type 2 diabetes: which is the right road to take?

Koufakis, T., Παπάνας, Ν., Zebekakis, P. E., & Kotsa, K. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1942843 · Cited by 12

Therapeutic Applications of Plant and Nutraceutical-Based Compounds for the Management of Type 2 Diabetes Mellitus: A Narrative Review

Dinesh, S., Sharma, S., & Chourasiya, R. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230505140206 · Cited by 12

Combined Placental Mesenchymal Stem Cells with Guided Nanoparticles Effective Against Diabetic Nephropathy in Mouse Model

Wang, K., Liu, T., Zhang, Y., Lv, H., Yao, H., Zhao, Y., Li, J., & Li, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s446733 · Cited by 11

Quantitative determination of lobeglitazone sulfate and glimepiride in combined tablet by robust high‐performance thin layer chromatographic method

Sen, A. K., Sarkar, T., Sen, D. B., Maheshwari, R. A., Zanwar, A. S., & Dumpala, R. L. (2024) · Separation Science Plus · doi:10.1002/sscp.202400059 · Cited by 11

Harnessing phytochemicals to combat diabetes: Insights into molecular pathways and therapeutic advances

Situmorang, P. C., Zuhra, C. F., Lutfia, A., Pasaribu, K. M., Hardiyanti, R., & Nugraha, A. P. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106799 · Cited by 18

Role of PPAR-γ in diabetes-induced testicular dysfunction, oxidative DNA damage and repair in leptin receptor-deficient obese type 2 diabetic mice

Alfarhan, M. W., Al‐Hussaini, H., & Kilarkaje, N. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109958 · Cited by 11

Pioglitazone inhibits oxidative stress, MMP-mediated inflammation and vascular dysfunction in high glucose-induced human saphenous vein grafts

Onursal, C., Reel, B., Bintepe, C., Güzeloğlu, M., Ersoy, N., & Bağrıyanık, A. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108421 · Cited by 11

A Critical Review on the Long-Term COVID-19 Impacts on Patients With Diabetes

Ashique, S., Mishra, N., Garg, A., Garg, S., Farid, A., Rai, S., Gupta, G., Dua, K., Paudel, K. R., & Taghizadeh‐Hesary, F. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.02.029 · Cited by 11

Synthesis, Characterization, and Pharmacokinetic Studies of Thiazolidine-2,4-Dione Derivatives

Ansari, B., Khan, H. Z., Jan, M. S., Alsharif, K. F., Alzahrani, K. J., Rashid, U., & Pirzada, A. S. (2023) · Journal of Chemistry · doi:10.1155/2023/9462176 · Cited by 10

Immunomodulation through Nutrition Should Be a Key Trend in Type 2 Diabetes Treatment

Napiórkowska-Baran, K., Treichel, P., Czarnowska, M., Drozd, M., Koperska, K., Węglarz, A., Schmidt, O., Darwish, S., Szymczak, B., & Bartuzi, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073769 · Cited by 11

Metformin as a Potential Prevention Strategy for Alzheimer’s Disease and Alzheimer’s Disease Related Dementias

Tahmi, M., Benitez, R., & Luchsinger, J. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240495 · Cited by 11

FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data

Boutari, C., Triantafyllou, A., Papalavrentios, L., Goulis, I., & Sinakos, E. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128374854250709050425 · Cited by 11

Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice

Seo, D. H., Suh, Y. J., Cho, Y., Ahn, S. H., Seo, S., Hong, S., Lee, Y., Choi, Y. J., Lee, E. J., & Kim, S. H. (2022) · Yonsei Medical Journal · doi:10.3349/ymj.2022.63.9.825 · Cited by 10

Citrus nutraceutical eriocitrin and its metabolites are partial agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a molecular docking and molecular dynamics study

Gangadhariah, M. H., Pardhi, T. R., Ravilla, J., Chandra, S., & Singh, S. A. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2162127 · Cited by 11

In Silico Identification of Peptides with PPARγ Antagonism in Protein Hydrolysate from Rice (Oryza sativa)

Ruiz-López, F. D. J., Espinosa-Rodríguez, B. A., Silva-Mares, D. A., González-Martínez, B. E., Lomelí, M. L.-C., Méndez-López, L. F., & Vázquez-Rodríguez, J. A. (2023) · Pharmaceuticals · doi:10.3390/ph16030440 · Cited by 11

Molecular Processes Involved in the Shared Pathways between Cardiovascular Diseases and Diabetes

Tokarek, J., Budny, E., Saar, M., Stańczak, K., Wojtanowska, E., Młynarska, E., Rysz, J., & Franczyk, B. (2023) · Biomedicines · doi:10.3390/biomedicines11102611 · Cited by 12

Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment

Vu, H. T., Nguyen, V. D., Ikenaga, H., & Matsubara, T. (2024) · Biomedicines · doi:10.3390/biomedicines12081876 · Cited by 9

From Current Therapeutics to Multitarget Ligands: A Review of Diabetes Pharmacological Treatments

Cabré, F., Centelles, J. J., & Cascante, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091125 · Cited by 12

Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective

Aberer, F., Pieber, T. R., Eckstein, M. L., Sourij, H., & Moser, O. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061180 · Cited by 10

Regulation of adipogenesis through retinoid X receptor and/or peroxisome proliferator-activated receptor by designed lignans based on natural products in 3T3–L1 cells

Nakashima, K., Okamura, M., Matsumoto, I., Kameda, N., Tsuboi, T., Yamaguchi, E., Itoh, A., & Inoue, M. (2023) · Journal of Natural Medicines · doi:10.1007/s11418-022-01674-7 · Cited by 9

Association of Acarbose with Decreased Muscle Mass and Function in Patients with Type 2 Diabetes: A Retrospective, Cross-Sectional Study

Jiang, L., Xu, X., Luo, M.-H., Wang, H., Ding, B., Yan, R., Hu, Y., & Ma, J. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01151-6 · Cited by 9

Peroxisome proliferator-activated receptor-gamma (PPARγ) and its immunomodulation function: current understanding and future therapeutic implications

Trindade‐da‐Silva, C. A., Clemente‐Napimoga, J. T., Abdalla, H. B., Basting, R. T., & Napimoga, M. H. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2071697 · Cited by 9

Synthesis of 2,4-diarylthiazoles throuth palladium-catalyzed cyclization of sulfoxonium ylides and benzothioamide

Lü, Y.-X., Zhu, L., Lv, T.-K., & Chen, B. (2022) · Tetrahedron Letters · doi:10.1016/j.tetlet.2022.154051 · Cited by 9

Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)

Khan, A., Ross, H. M., Parra, N. S., Chen, S. L., Chauhan, K., Wang, M., Yan, B. M., Magagna, J., Beiriger, J., Shah, Y., et al. (2022) · Livers · doi:10.3390/livers2040022 · Cited by 9

Identification and screening of potential inhibitors obtained from Plumeria rubra L. compounds against type 2 diabetes mellitus

Hazra, S., Aziz, A., & Sharma, S. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2153924 · Cited by 10

A Narrative Review of the Interplay Between Carbohydrate Intake and Diabetes Medications: Unexplored Connections and Clinical Implications

Mphasha, M. H., & Vagiri, R. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020624 · Cited by 12

Thiazolidinedione derivatives: emerging role in cancer therapy

Latambale, G., & Juvale, K. (2025) · Molecular Diversity · doi:10.1007/s11030-024-11093-3 · Cited by 9

Diabetes management in maternally inherited diabetes and deafness ( MIDD ): A review and a proposed treatment algorithm

Chaudhry, A., Thompson, D. M., & Chanoine, J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70240 · Cited by 8

Potensi Senyawa Fitokimia pada Tumbuhan dalam Menurunkan Kadar Glukosa Darah pada Diabetes Melitus

Budianto, R. E., Linawati, N. M., Arijana, I. G. K. N., Wahyuniari, I. A. I., & Wiryawan, I. G. N. S. (2022) · Jurnal Sains dan Kesehatan · doi:10.25026/jsk.v4i5.1259 · Cited by 8

Etiology of Drug-Induced Edema: A Review of Dihydropyridine, Thiazolidinedione, and Other Medications Causing Edema

Sinnathamby, E. S., Urban, B., Clark, R. A., Roberts, L. T., Witt, A. J. D., Wenger, D. M., Mouhaffel, A., Willett, O., Ahmadzadeh, S., Shekoohi, S., et al. (2024) · Cureus · doi:10.7759/cureus.53400 · Cited by 8

Protein Concentrates on Tepary Bean (Phaseolus acutifolius Gray) as a Functional Ingredient: In silico Docking of Tepary Bean Lectin to Peroxisome Proliferator-Activated Receptor Gamma

López-Ibarra, C., Ruiz-López, F. D. J., Villarreal, M. B., González, J. G. B., Rodríguez-Romero, B. A., González-Martínez, B. E., Lomelí, M. L.-C., & Vázquez-Rodríguez, J. A. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.661463 · Cited by 8

Simultaneous Quantification of Pioglitazone and Omarigliptin in Rat Plasma by UHPLC-MS/MS and Its Application to Pharmacokinetic Study after Coadministration of the Two Drugs

Wang, L., Wang, J., Lin, C., Wang, F., Xiang-ping, L., & Liu, W. (2021) · Journal of Analytical Methods in Chemistry · doi:10.1155/2021/6693366 · Cited by 8

Dual Modulation of Adipogenesis and Apoptosis by PPARG Agonist Rosiglitazone and Antagonist Betulinic Acid in 3T3-L1 Cells

Sriboonaied, P., Phuangbubpha, P., Saetan, P., Charoensuksai, P., & Charoenpanich, A. (2025) · Biomedicines · doi:10.3390/biomedicines13061340 · Cited by 10

Lysyl oxidase inhibits BMP9-induced osteoblastic differentiation through reducing Wnt/β-catenin via HIF-1a repression in 3T3-L1 cells

Zhang, J., Ye, F.-L., Ye, A., & He, B. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-04251-0 · Cited by 7

Treating Type 2 Diabetes With Early, Intensive, Multimodal Pharmacotherapy: Real‐World Evidence From an International Collaborative Database

Anson, M., Malik, A. I., Zhao, S. S., Austin, P. J., Hernández, G., Jaffar, S. S., Garrib, A. V., Cuthbertson, D. J., & Alam, U. (2024) · Journal of Diabetes Research · doi:10.1155/2024/3470654 · Cited by 7

Synthesis of novel quinazolinone-triheterocyclic hybrides as dual inhibition of urease and ache

Menteşe, E., Güzel, Y. Ü., Akyüz, G., & Karaali, N. (2024) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-024-03080-0 · Cited by 7

Computational Drug Design Approaches for the Identification of Novel Antidiabetic Compounds from Natural Resources through Molecular Docking, ADMET, and Toxicological Studies

Akter, B., Uddin, M. S., Islam, M. R., Ahamed, K. U., Aktar, M. N., Hossain, M. K., Salamatullah, A. M., & Bourhia, M. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01540-1 · Cited by 7

Empowering Pharmacists in Type 2 Diabetes Care: Opportunities for Prevention, Counseling, and Therapeutic Optimization

Uddin, S., Machado, M. S., Alshahrouri, B., Echeverri, J. I., Rico, M. C., Rao, A. D., Ruchalski, C., & Barrero, C. A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113822 · Cited by 11

Ectopic Overexpression of PPARγ2 in the Heart Determines Differences in Hypertrophic Cardiomyopathy After Treatment With Different Thiazolidinediones in a Mouse Model of Diabetes

Cao, X., Mao, M., Diao, J., Hou, Y., Hong, S., Gan, Y., Li, J., Tong, X., Wu, C., Zuo, Z., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.683156 · Cited by 7

Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus

Mu, L., Wang, Z., Ren, J., Xiong, X., Jin, Z., & Liu, X. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00797-x · Cited by 7

Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries

Dutt, C., Salles, J. E. N., Joshi, S., Nair, T., Chowdhury, S., Mithal, A., Mohan, V., Kasliwal, R. R., Sharma, S., Tijssen, J. G. P., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 7

A Scoping Review of the Use of Pioglitazone in the Treatment of Temporo-Mandibular Joint Arthritis

Turosz, N., Chęcińska, K., Chęciński, M. A., Kamińska, M., Nowak, Z., Sikora, M., & Chlubek, D. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416518 · Cited by 7

Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine

Tessier, N., Moawad, F., Amri, N., Brambilla, D., & Martel, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081200 · Cited by 7

Design, Synthesis, molecular dynamic analysis, and In-Vivo anti-diabetic evaluation of novel hydrazine carboximidamide derivatives

Fathi, H., Naderi, N., Hashemi, S., Pourbaba, Y., Garmabdari, A., Rezaee, E., Mahboubi‐Rabbani, M., & Tabatabai, S. A. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101791 · Cited by 6

Thiazolidinediones (TZDs)

Won, J. C. (2021) · Stroke revisited · doi:10.1007/978-981-16-5123-6_11 · Cited by 9

Exploring the Potential Benefits and Risks of 2,4-Thiazolidinediones (TZDs) in the Management of Diabetes and Related Conditions

Kumari, D. (2023) · Journal of Pharmacology and Drug Delivery · doi:10.59462/jpdd.1.1.101 · Cited by 1

Thiazolidinedione safety

Kung, J., & Henry, R. R. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.691963 · Cited by 198

The safety of thiazolidinediones

Tolman, K. G. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.534982 · Cited by 54

Thiazolidinediones: a review of their benefits and risks.

Ovalle, F., & Fernando, O.-B. J. (2002) · PubMed · Cited by 19